5-AMINO-1MQ 50MG CAPSULES | FUTUREPROOF PEPTIDES

5-Amino-1MQ 50mg Capsules by Futureproof Peptides are presented as a research product for customers seeking a clearly identified small-molecule compound in a convenient capsule format. Each product is labelled as containing 50mg of 5-Amino-1MQ per capsule, based on the product name provided. Also known as 5-amino-1-methylquinolinium, 5-Amino-1MQ is a small-molecule compound studied in scientific research relating to nicotinamide N-methyltransferase (NNMT). It is important to note that 5-Amino-1MQ is not a peptide, despite often being discussed alongside research peptides.

PRODUCT OVERVIEW

Futureproof Peptides 5-AMINO-1MQ 50mg Capsules provide a clearly named research compound in capsule form. The 50mg quantity refers to the stated amount per capsule in the product name.

5-Amino-1MQ has attracted scientific interest because of its relationship with NNMT, an enzyme involved in nicotinamide metabolism and methylation pathways. Published research has examined NNMT biology and small-molecule NNMT inhibitors in laboratory and preclinical settings.

For researchers and purchasers evaluating this type of compound, accurate identification and clear product information are important. This product page therefore focuses on the compound’s research context and stated product format without making unsupported claims about human outcomes.

WHY CHOOSE 5-AMINO-1MQ 50MG CAPSULES?

When selecting a specialist research compound, customers should look for clear information about the product identity, format and intended designation.

This Futureproof Peptides product is identified as 5-AMINO-1MQ 50mg Capsules, providing a straightforward product name and stated quantity. The capsule format may be relevant for product identification and inventory purposes, while the clearly stated compound name helps distinguish the product from other NNMT-related research materials.

5-Amino-1MQ has an established place in published preclinical and laboratory literature concerning NNMT inhibition. Scientific interest in this area includes the role of NNMT in metabolic pathways and the development of compounds used to investigate enzyme activity and related biological mechanisms.

Customers should assess product information carefully and seek clarification where specifications or documentation are required. No purity percentage, certificate of analysis, batch information, storage specification or manufacturing standard is claimed here unless separately provided and verified by the manufacturer or supplier.

RESEARCH INFORMATION

5-Amino-1MQ is a small-molecule compound investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme involved in the metabolism of nicotinamide and methyl-group transfer processes, making it a subject of interest across several areas of biochemical and metabolic research.

Published scientific literature has explored small-molecule NNMT inhibitors in enzyme assays, cell-based research and animal models. Research involving 5-amino-1-methylquinolinium and related compounds has contributed to the broader scientific investigation of NNMT activity and its role in cellular metabolic pathways.

Importantly, findings from laboratory and animal research should not be presented as proven outcomes in humans. Research results may depend on the study model, methodology and experimental conditions. The existence of preclinical research does not establish a medical use or guarantee any physiological effect.

For customers wishing to explore the published scientific record, relevant literature can be located through PubMed, including research on selective small-molecule inhibitors of NNMT and their use in preclinical models. General compound information may also be reviewed through the National Library of Medicine’s PubChem resources.

QUALITY & TRUST

Trust begins with accurate product information. The product name clearly identifies the compound, stated 50mg quantity and capsule format.

Where customers require additional documentation, it is sensible to review the information supplied specifically for the product and contact the supplier for clarification. Product-specific claims about independent testing, purity, batch traceability, certificates of analysis or manufacturing standards should only be relied upon when supporting documentation is actually available.

Peptide Depot should present research products with clear descriptions and appropriate labelling. Transparency is especially important when customers are evaluating specialist compounds and comparing available product information.

BUYING WITH CONFIDENCE

Before purchasing specialist research compounds, customers should consider several important factors: clear compound identification, transparent specifications, appropriate product labelling, accessible customer support and clear ordering information.

Customers should also understand the distinction between a research compound and a licensed medicine. In the UK, medicines are subject to specific legal and regulatory requirements. Information from the Medicines and Healthcare products Regulatory Agency (MHRA) and UK legislation can help customers understand the broader regulatory framework surrounding medicinal products.

Where product documentation is important to a purchasing decision, customers should request or review verifiable information rather than relying on unsupported claims.

IMPORTANT RESEARCH-USE NOTICE

5-Amino-1MQ 50mg Capsules are presented as a research product and are not presented on this page as a medicine or treatment. This product description does not provide medical advice, dosing instructions or claims of therapeutic benefit. Scientific research discussed above should not be interpreted as evidence of proven human outcomes.